The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Clinical assessment of the long-term risk of fracture in patients with rheumatoid arthritis.
Open accessAbstract
Objective: To determine whether patients with rheumatoid arthritis (RA) have an increased risk of fracture, and to estimate their long‐term absolute fracture risk. Methods: We studied patients with RA ages ≥40 years in the British General Practice Research Database, each matched by age, sex, calendar time, and practice to 3 control patients. Incident fractures, as recorded in the computerized medical records, were ascertained over a median followup of 7.6 years. The fracture rate in RA patients compared with controls was adjusted for smoking, body mass index (BMI), and several clinical risk factors, and Cox proportional hazards models were used to calculate the relative risk (RR) of fracture in RA. A risk score was then developed to provide an estimate of the 5‐ and 10‐year fracture risk among RA patients. Results: There were 30,262 patients with RA, of whom 2,460 experienced a fracture during followup. Compared with controls, patients with RA had an increased risk of fracture, which was most marked at the hip (RR 2.0, 95% confidence interval [95% CI] 1.8–2.3) and spine (RR 2.4, 95% CI 2.0–2.8). Indicators of a substantially elevated risk of fracture (at the hip) included >10 years' duration of RA (RR 3.4, 95% CI 3.0–3.9), low BMI (RR 3.9, 95% CI 3.1–4.9), and use of oral glucocorticoids (RR 3.4, 95% CI 3.0–4.0). Modeling of the long‐term risk profiles revealed that, for example, in a woman age 65 years with longstanding RA whose risk factors also included low BMI, a history of fracture, and frequent use of oral glucocorticoids, the 5‐year risk of hip fracture was 5.7% (95% CI 5.3–6.1%). Conclusion: Patients with RA are at increased risk of osteoporotic fractures. This increased risk is attributable to a combination of disease activity and use of oral glucocorticoids.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition to focal bone erosions and periarticular bone loss, systemic bone loss and increased fracture risk are important components of RA (224, 239, 420 -422).”
From Receptor Activator of Nuclear Factor κB Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease (2008) · cites this paper as [422]
Citations
Cites
Arnett, F. C., Edworthy, S. M., Bloch, D. A., McShane, D. J., Fries, J. F., Cooper, N. S., Healey, L. A., Kaplan, S. R., Liang, M. H., Luthra, H. S., et al. (1988) · Arthritis & Rheumatism · doi:10.1002/art.1780310302 · Cited by 19,753
Revised Criteria for the Classification of Rheumatoid Arthritis
Arnett, F. C. (1990) · Orthopaedic Nursing · doi:10.1097/00006416-199003000-00011 · Cited by 7,742
Kelley, W. N. (1985) · Virtual Defense Library (Ministerio de Defensa) · Cited by 1,641
Use of Inhaled Corticosteroids and Risk of Fractures
van Staa, T. P., Leufkens, H. G. M., & Cooper, C. C. (2001) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2001.16.3.581 · Cited by 1,297
Self-citationThe epidemiology of corticosteroid-induced osteoporosis: a meta-analysis
Staa, T. P. V., Staa, T. P. V., Staa, T. P. V., Leufkens, H. G. M., & Cooper, C. (2002) · Osteoporosis International · doi:10.1007/s001980200108 · Cited by 1,294
Self-citationUse of oral corticosteroids and risk of fractures
Van Staa, T. P., Leufkens, H. G. M., Abenhaim, L., Zhang, B., & Cooper, C. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.6.993 · Cited by 1,263
Self-citationKanis, J. А., Borgström, F., Laet, C. E. D. H. D., Johansson, H., Johnell, O., Jönsson, B., Odén, A., Zethraeus, N., Pfleger, B., & Khaltaev, N. (2004) · Osteoporosis International · doi:10.1007/s00198-004-1780-5 · Cited by 1,257
Ten Year Probabilities of Osteoporotic Fractures According to BMD and Diagnostic Thresholds
Kanis, J. А., Johnell, O., Odén, A., Laet, C. E. D. H. D., Dawson, A., & Jönsson, B. (2001) · Osteoporosis International · doi:10.1007/s001980170006 · Cited by 833
O'Neill, D. D. A. M. G. A. J. W. D. L. A. A. J. C. J. R. B. W. S. K. I. J. O. J. G. V. A. R. G. P. C. T. G. H. G. H. D. W. N. J. C. K. A. O. J. T. W. F. S. L. A. I. F. C. B. B. B. B. C. C. D. E. F. G. H. H. J. J. J. K. K. L. L. L. M. M. M. P. P. P. R. R. R. S. S. T. W. W. Y. R. (2002) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2002.17.4.716 · Cited by 713
The UK General Practice Research Database
Walley, T., & Mantgani, A. (1997) · The Lancet · doi:10.1016/s0140-6736(97)04248-7 · Cited by 624
Deighton, C. (1994) · Annals of the Rheumatic Diseases · doi:10.1136/ard.53.2.89-a · Cited by 458
Low-Dose Prednisone Induces Rapid Reversible Axial Bone Loss in Patients with Rheumatoid Arthritis
Laan, R., van Riel, P. L. C. M., van de Putte, L. B. A., van Erning, L. J. T. O., Hof, M. A. V., & Lemmens, J. A. M. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-10-199311150-00001 · Cited by 410
Peel, N. F. A., Moore, D., Barrington, N. A., Bax, D. E., & Eastell, R. (1995) · Annals of the Rheumatic Diseases · doi:10.1136/ard.54.10.801 · Cited by 377
Rheumatoid arthritis, corticosteroid therapy and hip fracture.
Cooper, C. C., Coupland, C. A. C., & Mitchell, M. (1995) · Annals of the Rheumatic Diseases · doi:10.1136/ard.54.1.49 · Cited by 348
Self-citationFractures after rheumatoid arthritis a population‐based study
Hooyman, J. R., Melton, L. J., Nelson, A. M., O’Fallon, W. M., & Riggs, B. L. (1984) · Arthritis & Rheumatism · doi:10.1002/art.1780271205 · Cited by 283
Pocock, S., McCormack, V., Gueyffier, F., Boutitie, F., Fagard, R. H., & Boissel, J. (2001) · BMJ · doi:10.1136/bmj.323.7304.75 · Cited by 272
Watson, D. J., Rhodes, T., Cai, B., & Guess, H. A. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.10.1105 · Cited by 237
Risk of vertebral fracture in women with rheumatoid arthritis.
Spector, T. D., Hall, G. M., McCloskey, E. V., & Kanis, J. (1993) · BMJ · doi:10.1136/bmj.306.6877.558 · Cited by 230
Determinants of axial bone loss in rheumatoid arthritis
Sambrook, P. N., Eisman, J. A., Champion, G. D., Yeates, M. G., POCOCK, N. A., & Eberl, S. (1987) · Arthritis & Rheumatism · doi:10.1002/art.1780300701 · Cited by 200
Reid, D. M., Kennedy, N., Smith, M. A., Tothill, P., & Nuki, G. (1982) · BMJ · doi:10.1136/bmj.285.6338.330 · Cited by 153
Threefold increased risk of hip fractures with rheumatoid arthritis in Central Finland
Huusko, T., Korpela, M. M., Karppi, P., Avikainen, V., Kautiainen, H., & Sulkava, R. O. (2001) · Annals of the Rheumatic Diseases · doi:10.1136/ard.60.5.521 · Cited by 147
Fractures in rheumatoid arthritis: an evaluation of associated risk factors.
Michel, B. A., Bloch, D. A., Wolfe, F., & Fries, J. F. (1993) · PubMed · Cited by 146
Vertebral Deformities in Rheumatoid Arthritis
Ørstavik, R., Haugeberg, G., Mowinckel, P., Høiseth, A. D., Uhlig, T., Falch, J. A., Halse, J., McCloskey, E. V., & Kvien, T. K. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.4.420 · Cited by 144
Predictors of fractures in early rheumatoid arthritis.
Michel, B. A., Bloch, D. A., & Fries, J. F. (1991) · PubMed · Cited by 144
van Staa, T. P., & Abenhaim, L. (1994) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.2630030106 · Cited by 138
Self-citationKröger, H., Honkanen, R., Saarikoski, S., & ALHAVA, E. M. (1994) · Annals of the Rheumatic Diseases · doi:10.1136/ard.53.1.18 · Cited by 130
Rheumatoid arthritis and bone mineral density in elderly women
Lane, N. E., Pressman, A. R., Star, V. L., Cummings, S. R., & Nevitt, M. C. (1995) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650100212 · Cited by 109
Glucocorticoids in the treatment of early and late RA
Bijlsma, J. W. J., Boers, M., Saag, K. G., & Furst, D. E. (2003) · Annals of the Rheumatic Diseases · doi:10.1136/ard.62.11.1033 · Cited by 92
Self-citationde Nijs, R. N. J. (2001) · British journal of rheumatology · doi:10.1093/rheumatology/40.12.1375 · Cited by 92
Intervention thresholds for osteoporosis
Kanis, J. A., Johnell, O., Odén, A., Laet, C. E. D. H. D., Oglesby, A. K., & Jönsson, B. (2002) · Bone · doi:10.1016/s8756-3282(02)00813-x · Cited by 88
Edwards, C. J., Arden, N., Fisher, D., Saperia, J., Reading, I., van Staa, T. P., & Cooper, C. C. (2005) · Lara D. Veeken · doi:10.1093/rheumatology/kei024 · Cited by 70
Self-citationØrstavik, R., Haugeberg, G., Uhlig, T., Mowinckel, P., Falch, J. A., Halse, J. I., & Kvien, T. K. (2004) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2003.005850 · Cited by 66
Bone Loss in Patients with Rheumatoid Arthritis
Kennedy, A. C., Smith, D. A., Buchanan, W. W., Anderson, J., & Jasani, M. K. (1975) · Scandinavian Journal of Rheumatology · doi:10.3109/03009747509095618 · Cited by 54
Osteoporosis in rheumatoid arthritis
Suzuki, Y., & Mizushima, Y. (1997) · Osteoporosis International · doi:10.1007/bf03194376 · Cited by 44
Osteoporosis in Rheumatoid Arthritis
Kameyama, O., 健, 中., 浩史, 川., 博史, 大., & 亮惠, 小. (1997) · Nihon Riumachi, Kansetsu Geka Gakkai zasshi/Nihon Ryūmachi, Kansetsu Geka Gakkai zasshi · doi:10.11551/jsjd1982.16.259 · Cited by 38
Edwards, C. J., Arden, N., van Staa, T. P., Reading, I., Saperia, J., Fisher, D. J., & Cooper, C. C. (2005) · Lara D. Veeken · Cited by 21
Self-citation"Absolute" is inappropriate for quantitative risk estimation
Tunstall‐Pedoe, H. (2000) · BMJ · doi:10.1136/bmj.320.7236.723 · Cited by 12
van Staa, T. P., Abenhaim, L., Cooper, C. C., Zhang, B., & Leufkens, H. G. M. (2000) · Pharmacoepidemiology and Drug Safety · doi:10.1002/1099-1557(200009/10)9:5
Self-citationHarrell, F., Jr. (1996) · doi:10.1002/(sici)1097-0258(19960229)15:4
Flagged first, then by citations
Cited by
Sorted by citations
Glucocorticoid-induced osteoporosis: pathophysiology and therapy
CANALIS, E. M., Mazziotti, G., Giustina, A., & Bilezikian, J. P. (2007) · Osteoporosis International · doi:10.1007/s00198-007-0394-0 · Cited by 1,131
“This recommendation is consistent with data demonstrating that fracture risk is highest during the time of glucocorticoid exposure [104].”
BackgroundGabriel, S. E., & Michaud, K. D. (2009) · Arthritis Research & Therapy · doi:10.1186/ar2669 · Cited by 893
Understanding the dynamics: pathways involved in the pathogenesis of rheumatoid arthritis.
Choy, E. (2012) · Rheumatology · doi:10.1093/rheumatology/kes113 · Cited by 816
Kearns, A. E., Khosla, S., & Kostenuik, P. J. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0014 · Cited by 824
A comprehensive overview on osteoporosis and its risk factors
Pouresmaeili, F., Dehghan, B. K., Kamarehei, M., & Meng, G. Y. (2018) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s138000 · Cited by 636
“138 142 Histomorphometric and biochemical markers analysis indicates that generalized bone loss in RA is related to a decrease in bone formation and increase in bone resorption.”
Background
Metadata
- Authors
- Staa, T. P. V., Geusens, P., Bijlsma, J. W. J., Leufkens, H. G. M., & Cooper, C.
- Affiliations
- University of Southampton (GB)
- University Medical Center Utrecht (NL)
- Utrecht University (NL)
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 2006-09-28
- Volume
- 54
- Issue
- 10
- Pages
- 3104-3112
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W2098986981
- Cited by
- 587
- References
- 39
- Citations by year
- 2026: 8 · 2025: 15 · 2024: 19 · 2023: 21 · 2022: 26 · 2021: 56 · 2020: 44 · 2019: 37 · 2018: 50 · 2017: 40 · 2016: 32 · 2015: 30 · 2014: 34 · 2013: 33 · 2012: 38
- FWCI
- 11.88
- Type
- journal article
- Language
- en
- Open access
- green
- dspace.library.uu.nl
- Licence
- Locations
- Arthritis & Rheumatism (publishedVersion)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (publishedVersion)
- Document Server@UHasselt (UHasselt) (submittedVersion)
- Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
- ePrints Soton (University of Southampton) (submittedVersion)
- Topics
- Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
- Keywords
- rheumatoid arthritis, fracture risk, osteoporotic fractures, hip fracture, spinal fractures, oral corticosteroids, body mass index, disease duration
- MeSH terms
- Adult, Aged, Aged, 80 and over, Algorithms, Arthritis, Rheumatoid, Female, Glucocorticoids, Humans, Male, Middle Aged, Osteoporosis, Risk Factors, Time Factors, Cohort Studies, Case-Control Studies, Fractures, Bone
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review